Cisplatine Hospira 100 mg/100 ml Onco-Tain solution injectable

DRUG2 trials

Sponsors

Institut Gustave Roussy, Groupe Oncologie Radiotherapie Tete Cou

Conditions

Thromboprophylaxis in good and intermediate prognosis advanced germ cell tumorslocally advanced squamous cell carcinoma

Phase 2

A phase II randomized trial, non comparative, evaluating chemotherapy associated cisplatin, 5-fluorouracil and docetaxel at adapted doses in patients with locally advanced squamous cell carcinoma

CompletedCTIS2024-512456-38-00

Groupe Oncologie Radiotherapie Tete Coulocally advanced squamous cell carcinoma

Start: 2021-02-04End: 2025-08-05Target: 105Updated: 2025-03-03

Phase 3

Thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors (GIG-T)

RecruitingCTIS2022-502426-41-00

Institut Gustave RoussyThromboprophylaxis in good and intermediate prognosis advanced germ cell tumors

Start: 2023-10-17Target: 387Updated: 2026-01-13